CeriBell, Inc. (CBLL) vs LB Pharmaceuticals Inc Common Stock (LBRX)
A side-by-side comparison of CeriBell, Inc. and LB Pharmaceuticals Inc Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBLL
CeriBell, Inc.
$24.70HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
LBRX
LB Pharmaceuticals Inc Common Stock
$34.88HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
Total return — CBLL vs LBRX
growth of $100 · dividends reinvested · last 1yCBLL +115.1% (+115.1%/yr)LBRX +100.1% (+100.1%/yr)CBLL compounded faster over this window
CBLL LBRX
CBLL vs LBRX: by the numbers
- •LBRX is the larger company ($1.00B vs $937M market cap).
- •Both run net losses; LBRX's is the smaller (0.00% vs -64.73% net margin).
Metrics side by side
Valuation
| Metric | CBLL | LBRX |
|---|---|---|
| P/S ratio | 9.19 | N/A |
| P/B ratio | 7.30 | 3.01 |
Profitability
| Metric | CBLL | LBRX |
|---|---|---|
| Gross margin | 88.90% | 0.00% |
| Operating margin | -68.62% | 0.00% |
| Net margin | -64.73% | 0.00% |
| ROE | -51.43% | -25.78% |
| ROIC | -46.54% | -28.14% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.